The document discusses HIV prevention methods, specifically the prophylactic drugs PrEP and PEP. PrEP is a daily pill that significantly reduces the risk of HIV transmission for high-risk individuals, while PEP is a short-term treatment initiated shortly after potential HIV exposure. Both methods contribute to efforts aimed at HIV elimination.

1. PrEP and PEP for HIV Prevention
Rodney Goodie

2. Introduction
A fellowship-trained and board-certified spine specialist, Dr. Anil Kumar Kesani
practices at SpineMD, where he focuses on minimally invasive spinal surgery and
disc replacements. Dr. Anil Kesani incorporates the latest developments and
treatments in spinal care to speed up and optimize patient outcomes.

3. Before starting his current role as CEO of the St. Hope Foundation in Houston, Robert
Goodie served as executive director of the Donald R. Watkins Memorial Foundation. In his
work with St. Hope, Robert Goodie oversees several health care delivery and prevention
programs focused on chronic and communicable illnesses such as hepatitis C and HIV.

4. The prophylactic drugs PrEP and PEP have greatly advanced progress towards HIV
elimination. PrEP is a daily pill that can reduce the likelihood of developing HIV. PrEP
is recommended for people who have an elevated risk of contracting HIV. This
includes people with HIV positive partners, people with multiple sexual partners, or
people who inject drugs using shared needles.

5. When taken as recommended and combined with medical monitoring, PrEP can
reduce HIV transmission through sex by 99 percent and through intravenous
drug use by 70 percent. On the other hand, PEP is a short-term prophylactic
intended for people who have been exposed to HIV. PEP is most effective when
started less than three days after exposure. A PEP course is prescribed for 28
days.